v3.26.1
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
2006 Stock Option Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Status of Stock Option Plan

 

 

2026

 

2025

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Remaining Contractual Life

 

Options

 

 

Weighted Average Exercise Price

 

 

Remaining Contractual Life

Outstanding at beginning of year

 

 

37,696

 

 

$

10.61

 

 

 

 

 

37,696

 

 

$

10.61

 

 

 

Outstanding at end of period

 

 

37,696

 

 

 

10.61

 

 

0.3 years

 

 

37,696

 

 

 

10.61

 

 

1.3 years

Options exercisable at end of period

 

 

37,696

 

 

$

10.61

 

 

0.3 years

 

 

37,696

 

 

$

10.61

 

 

1.3 years

2012 Equity Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Status of Stock Option Plan

A summary of the status of stock options under the 2012 EIP for the six months ended June 30, 2026 and 2025 is presented below:

 

 

 

2026

 

2025

 

 

Options

 

 

Exercise Price

 

 

Intrinsic Value

 

 

Remaining Contractual Life

 

Options

 

 

Exercise Price

 

 

Intrinsic Value

 

 

Remaining Contractual Life

Outstanding at beginning of year

 

 

17,749

 

 

$

8.68

 

 

$

106,000

 

 

 

 

 

17,749

 

 

$

8.68

 

 

$

28,000

 

 

 

Exercised

 

 

(3,598

)

 

 

9.83

 

 

$

20,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

14,151

 

 

$

8.38

 

 

$

133,000

 

 

6.5 years

 

 

17,749

 

 

$

8.68

 

 

$

53,000

 

 

6.6 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at end of period

 

 

6,585

 

 

$

8.95

 

 

$

58,000

 

 

4.9 years

 

 

7,662

 

 

$

9.72

 

 

$

15,000

 

 

3.8 years

 

Schedule of Unvested Restricted Stock Activity

A summary of the status of unvested restricted stock awards under the 2012 EIP for the six months ended June 30, 2026 and 2025 is as follows:

 

 

 

For the Six Months
Ended June 30, 2026

 

 

 

Weighted Average Grant Price (per Share)

 

 

For the Six Months
Ended June 30, 2025

 

 

 

Weighted Average Grant Price (per Share)

 

Unvested shares outstanding at beginning of year

 

 

32,538

 

 

$

 

7.91

 

 

 

77,231

 

 

$

 

8.19

 

Vested

 

 

(10,656

)

 

 

 

7.89

 

 

 

(44,416

)

 

 

 

8.39

 

Unvested shares outstanding at end of period

 

 

21,882

 

 

$

 

7.92

 

 

 

32,815

 

 

$

 

7.92

 

2025 Equity Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Status of Stock Option Plan

A summary of the status of stock options under the 2025 EIP for the six months ended June 30, 2026 is presented below:

 

 

 

2026

 

 

 

Options

 

 

Exercise Price

 

 

Intrinsic Value

 

 

Remaining Contractual Life

 

Outstanding at beginning of year

 

 

43,175

 

 

$

14.85

 

 

 

 

 

 

 

Outstanding at end of period

 

 

43,175

 

 

$

14.85

 

 

$

128,000

 

 

9.4 years

 

Options exercisable at end of period

 

 

 

 

$

 

 

$

 

 

 

 

 

Schedule of Unvested Restricted Stock Activity

A summary of the status of unvested restricted stock awards under the 2025 EIP for the six months ended June 30, 2026 is as follows:

 

 

 

 

At June 30, 2026

 

 

Weighted Average Grant Price (per Share)

 

Unvested shares outstanding at beginning of year

 

 

47,556

 

 

$

12.36

 

Granted

 

 

29,390

 

 

 

14.57

 

Vested

 

 

(13,999

)

 

 

11.64

 

Unvested shares outstanding at end of period

 

 

62,947

 

 

$

13.55

 

2025 Equity Incentive Plan [Member] | Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Awards Granted

The Compensation Committee of the Board of Directors granted restricted stock awards under the 2025 EIP during the six months ended June 30, 2026 as follows:

 

Grant Date

 

Number of Restricted Stock Awards

 

 

Vesting

 

Fair Value per Share of Award on Grant Date

 

 

Awardees

 

 

 

 

 

 

 

 

 

 

 

March 18, 2026

 

 

4,349

 

 

100% on March 18, 2027

 

$

14.57

 

 

Non-employee directors

March 18, 2026

 

 

25,041

 

 

25% per year for four years with first vesting on March 18, 2027

 

$

14.57

 

 

Employees